![](https://lumicks.com/wp-content/uploads/2021/07/social-media-INmune-Bio_-Twitter-and-linkedin.png)
INmune Bio is employing the z-Movi® cell avidity analysis platform to demonstrate that the mechanism of action of the tumor-priming is the increase in NK cell:tumor cell avidity. Early data acquired by the z-Movi® support their hypothesis that increased cell avidity enhances NK cell killing of tumor cells. This allows…
j.yeh22 July 2021